Clinical utility of ubiliquins in breast cancer (Dimensions).

Authors: Alex Glynn

Publication:

Published: Unknown date

Source: Crossref

Back to Search View Original Cite This Article

Abstract

<jats:title>Abstract</jats:title> <jats:p>Does breast cancer-specific evidence support ubiquilins as prognostic or predictive biomarkers, mechanistic regulators, or therapeutic targets?</jats:p>

Keywords

abstract does breast cancerspecific evidence

Clinical utility of ubiliquins in breast cancer (Dimensions).

Abstract

Keywords

Related Articles

Clinical characteristics and machine learning-based prediction of postoperative enterocolitis in intestinal neuronal dysplasia: A 20-year retrospective study

Deployment protocol and base model jointly determine residual risk in rule-based clinical LLM supervision

Development and Validation of an Intratumoral–Peritumoral Radiomics-Clinical Model for Preoperative Prediction of Synchronous Liver Metastasis in Pancreatic Neuroendocrine Tumors

Integrating HPV self-sampling into antenatal care: prevalence, genotype distribution, clinical outcomes, and preventive implications among pregnant women in Thailand

Sacroiliac Joint Dysfunction and Associated Disability in the Immediate Postpartum Period: A Cross-Sectional Analysis for Clinical Screening and Rehabilitation